Skip to main content
Fig. 1 | Journal of Biomedical Science

Fig. 1

From: RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells

Fig. 1

The proliferation rates and FANCD2 monoubiquitination in A549 and A549/DDP cells treated with DDP. a The proliferation rates in A549/DDP cells 24 and 48 h after cisplatin treatment were significantly higher than those in A549 cells. b FANCD2 monubiquitination in A549 cells induced by cisplatin with different concentrations. c FANCD2 monubiquitination in A549/DDP cells induced by cisplatin with different concentrations. d The levels of FANCD2 monoubiquitination in A549/DDP cells were markedly higher than those in A549 cells after cisplatin treatment

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127